<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN">
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=UTF-8">
    <title>Description of interventions_4</title>
    <link href="data:image/x-icon;base64,iVBORw0KGgoAAAANSUhEUgAAAEoAAABJCAYAAACaRLDfAAAEaklEQVR42u2cv2oVQRTG7xv4CD5BsLbKCwg2NlYiaB2wUiwCVhYBsTAiCKlSBARDSjEEQUGCkM4QEAXlNmohvsCEb2Auu/fOzs75NzMbXRi4RO/e3d+e+eY7Z2Z2Nit8HH06c5svDtytzR23fnfLfw7/Nj/+4bbXnvqGz+Hv1+898/8X33my+9adnH13s4t47Bx8cLjZ2dqdlZYDCpCWv3dpfcODe310Mm1oiBzcSAyOBqgYtG/z39OBhic8dmPaoLoNkYuH1HQEUW7IClRoTUbYxtYe+UasQYUu2T1/1Si6fO0BG5I1qNCu3HxUL7r8DQouviSoEF3FR8ic0aw1UKHBhxWBhDDWuugaoILQTwpSLVCmsCwg1QRlAktTk9AwUob0ozsaDYFCboc0CN+BKGteC87b1OgWnmDKNQ+Bkrr/sSZ28v4ESoByfEwuqHDgnFrWQQRKGubQNUpJhApK0/h64DV0KSd1CFC6cDigtK6Z7LEkXQ5RmCuQ2qBw+Jst1QUlSSi1qy03KahQKOTC8gm+5Y9QIWlqlDasrASaK4oafkQTlKQbjhpRrjalhPv943du//arrLZ3Y3cBCp9P9z+LYQ3V6keb9kl9apM4AGBZtHPb8fZHFdfMsTnpEZBBfkyXakdUcPKcNEutP2snldoaJR3Jo0HA6Xba5VVLUBz9jWuvYTThpqE3Y+3w4RszUJxS0Yr+cmhTMm5AoAq5BSiWt5KUUgaFrnFQnJ7TCwiqPmXb/IY0iivqPZ2i9l2raZ8SoKi9p6/FlUe7kqCoetyvU2nae0PdQpP+rn/InJFPRnh6oNiBUQtUzFt1fRQ+x7zWPweqlkax0pn/oBoChQoAt3qAv7VgOhezsJr1Jy3RVhVvDVDW9qC1iKLaA5GPslrnXUKjqEW8HiiquKktbJhACtPLa6lJcW4tKjZvN9RKgaLmtb3aOZVy7owqVbStQVH1aaXMwinc5VQQWgPFmueTTun47jqxrked3I16xos+ucApA0fn9jgnyomqVkBxlgoMB0KNZX0j7l3DdHK0KZmBcBZiUScaSoNCVHCm1JNekZr3ac0Yh9pUrB4lnVbnLPvOsj/cRWQtLvvhLlXM2pElWZZIhfXr9Kf7evjFWYDiro0iLU+ULEnOhQVIL68+91BC99ICJVnHSdrfx7H6lNW1XUihAZYGKMnKYNbAJN2xkPJYFqDwcKX7ddgTu9IfTm0m1Ox6iGDp5gHRyA27oLFJB5oXM6ZSMYceSncsaHlB0TLkmNtNiX0OKHQxRJAGIK1l34tDsgs9FWXQwZxtaOE1JRZ7BtWrtdp79lrY2GhV0jaBVQuUGSQrWDVAmUPS8li1QFF2fqlWDDWsQylQGCWrvXdKww2XAKVdiRV1RW50WYJCFDX3Ii5EF0foLUA185YfTWCaoCYBKAYMFz2WamiAgk4WezmN5YHRBmlQTPi5oAKcC/sGRRwQWADCaNT1NUOgABndGd9p+v11pY6/8z/3w+pffG7p2s4BjkSc9cbCpq0AAAAASUVORK5CYII=" rel="icon" type="image/x-icon">
    <style>@import "https://fonts.googleapis.com/css?family=Source+Sans+Pro:ital,wgth:0,400;0,700;1,400;1,700";body {  font-family: "Source Sans Pro", sans-serif;  margin: 40px;}@media screen {  #backToTop {    position: fixed;    bottom: 0px;    left: 50%;    transform: translateX(-50%);    border-radius: 4px 4px 0 0;    padding: 4px 12px 4px 12px;    background: #1f3c73;    font-weight: bold;  }  #backToTop a {    color: white;  }}@media print {  #backToTop {    display: none;  }}table {  width: fit-content;  border-collapse: collapse;}th {  font-weight: bold;  background: LightGray;}td, th {  border: 1px solid LightGray;  padding: 8px;  font-size: 14px;  vertical-align: top;}caption {  font-weight: bold;  font-size: large;  text-align: left;  padding: 8px;}h1 {  font-size:38.5px;}h2 {  font-size:31.5px;}h1 small, h3 {  font-size:24.5px;}h2 small, h4 {  font-size:17.5px;}h3 small, h4 small, h5 {  font-size:14px;}h6 {  font-size:11.9px;}a {  color: #002d64;  text-decoration: none;}.byline {  font-weight: bold;  color: #002D64;}.disclaimer {  font-style: italic;}figure, table.analysis {  width: fit-content;  display: block;  margin-block-start: 1em;  margin-block-end: 1em;  margin-inline-start: 40px;  margin-inline-end: 40px;}thead tr td, th, figcaption, caption {  font-weight: bold;  background: LightGray;}span.inserted {  background-color: #e5ffcd;}span.deleted {  background-color: #e5ffcd;  text-decoration: line-through;}span.marker-yellow {  background-color: #ffff80;}ol ol {  list-style-type: lower-alpha;}ol ol ol {  list-style-type: lower-roman;}</style>
  </head>
  <body>
    <div class="logo">
      <svg xmlns="http://www.w3.org/2000/svg" height="57" viewBox="0 0 1138.5 192" width="338" xml:space="preserve">
        <path d="M86 .5v33a63.3 63.3 0 0 0 0 125v33a96 96 0 0 1 0-191zM106 .5v33a63.3 63.3 0 0 1 0 125v33a96 96 0 0 0 0-191z" fill="#1f3c73"></path>
        <path d="M93 0h6v192h-6z" fill="#a53995"></path>
        <path d="M93 0h6v192h-6zM82 44h8v6h-8z" fill="#a53995"></path>
        <path d="M63 58h40v6H63zM69 73h30v6H69zM78 86h36v6H78zM63 100h42v6H63zM60 114h28v6H60zM88 128h15v6H88zM84 140l6 6-6 6-6-6z" fill="#a53995"></path>
        <g aria-label="Cochrane" fill="#1f3c73" stroke-width="3.368">
          <path d="M256.96 82.722q-7.366 0-13.564-3.413-6.198-3.414-9.97-10.06-3.683-6.737-3.683-16.528 0-9.701 3.772-16.528 3.863-6.917 10.15-10.51 6.378-3.682 13.743-3.682 5.66 0 10.15 2.335 4.492 2.246 7.456 5.3l-7.007 8.443q-2.245-2.066-4.76-3.323-2.426-1.347-5.57-1.347-3.952 0-7.275 2.245-3.234 2.246-5.21 6.468-1.886 4.221-1.886 10.15 0 8.982 3.862 14.013 3.863 5.03 10.33 5.03 3.593 0 6.378-1.617 2.874-1.617 5.03-3.863l7.006 8.264q-7.365 8.624-18.953 8.624zM302.86 82.722q-5.659 0-10.689-2.695-4.94-2.784-7.994-7.994-3.054-5.3-3.054-12.665 0-7.456 3.054-12.665 3.054-5.21 7.994-7.905 5.03-2.784 10.689-2.784t10.599 2.784q4.94 2.695 7.994 7.905 3.054 5.21 3.054 12.665 0 7.365-3.054 12.665-3.054 5.21-7.994 7.994-4.94 2.695-10.599 2.695zm0-10.689q4.042 0 6.108-3.413 2.066-3.504 2.066-9.252 0-5.839-2.066-9.252-2.066-3.413-6.108-3.413-4.132 0-6.198 3.413-1.976 3.413-1.976 9.252 0 5.749 1.976 9.252 2.066 3.413 6.198 3.413zM352.98 82.722q-6.198 0-11.228-2.695-4.94-2.784-7.905-7.994-2.874-5.3-2.874-12.665 0-7.456 3.234-12.665 3.233-5.21 8.533-7.905 5.3-2.784 11.408-2.784 4.132 0 7.276 1.347 3.234 1.348 5.749 3.413l-6.198 8.534q-3.144-2.605-6.018-2.605-4.761 0-7.636 3.413-2.784 3.413-2.784 9.252 0 5.749 2.784 9.252 2.875 3.413 7.186 3.413 2.156 0 4.222-.898 2.066-.988 3.773-2.335l5.21 8.623q-3.324 2.874-7.186 4.132-3.863 1.167-7.546 1.167zM375.53 81.644V18.677h13.204v15.45l-.629 7.994q2.515-2.245 5.839-4.131 3.413-1.977 7.904-1.977 7.276 0 10.51 4.85 3.323 4.762 3.323 13.115v27.666h-13.204v-25.96q0-4.85-1.347-6.646-1.258-1.797-4.132-1.797-2.515 0-4.312 1.168-1.796 1.078-3.952 3.144v30.091zM426.82 81.644V37.091h10.779l.898 7.815h.36q2.425-4.491 5.838-6.647 3.413-2.246 6.827-2.246 1.886 0 3.144.27 1.257.18 2.156.628l-2.156 11.408q-1.168-.359-2.336-.539-1.078-.18-2.515-.18-2.515 0-5.3 1.887-2.694 1.797-4.49 6.288v25.869zM471.28 82.722q-6.108 0-9.701-3.862-3.593-3.953-3.593-9.612 0-7.006 5.928-10.959 5.929-3.952 19.133-5.3-.18-2.964-1.796-4.67-1.527-1.797-5.21-1.797-2.785 0-5.659 1.078-2.874 1.078-6.108 2.964l-4.76-8.713q4.221-2.605 8.982-4.222 4.85-1.616 10.06-1.616 8.533 0 13.114 4.94 4.58 4.94 4.58 15.18v25.51h-10.778l-.898-4.581h-.36q-2.784 2.515-6.018 4.132-3.144 1.527-6.916 1.527zm4.491-10.24q2.246 0 3.863-.988 1.706-1.078 3.413-2.785v-7.814q-7.006.898-9.701 2.874-2.695 1.886-2.695 4.491 0 2.156 1.348 3.234 1.437.988 3.772.988zM507.39 81.644V37.091h10.779l.898 5.659h.36q2.874-2.695 6.287-4.671 3.503-2.066 7.995-2.066 7.275 0 10.509 4.85 3.323 4.761 3.323 13.115v27.666h-13.204v-25.96q0-4.85-1.347-6.646-1.258-1.797-4.132-1.797-2.515 0-4.312 1.168-1.796 1.078-3.952 3.144v30.09zM578.71 82.722q-6.378 0-11.498-2.785-5.12-2.784-8.084-7.994-2.964-5.21-2.964-12.575 0-7.276 2.964-12.486 3.054-5.21 7.904-7.994 4.85-2.875 10.15-2.875 6.378 0 10.51 2.875 4.221 2.784 6.287 7.635 2.156 4.76 2.156 10.869 0 1.706-.18 3.413-.18 1.617-.36 2.425h-26.677q.898 4.85 4.042 7.186 3.144 2.246 7.545 2.246 4.761 0 9.612-2.964l4.4 7.994q-3.412 2.335-7.634 3.683-4.222 1.347-8.174 1.347zm-9.88-28.205h16.078q0-3.683-1.796-6.018-1.707-2.426-5.66-2.426-3.053 0-5.479 2.156-2.425 2.066-3.143 6.288z"></path>
        </g>
        <g aria-label="Library" fill="#a53995" stroke-width="3.368">
          <path d="M236.48 168.68v-58.925h7.455v52.547h25.78v6.378zM279.42 168.68v-43.655h7.366v43.655zm3.773-52.637q-2.156 0-3.593-1.258-1.348-1.347-1.348-3.593 0-2.155 1.348-3.503 1.437-1.347 3.593-1.347 2.155 0 3.503 1.347 1.437 1.348 1.437 3.503 0 2.246-1.437 3.593-1.348 1.258-3.503 1.258zM320.82 169.76q-3.054 0-6.378-1.437-3.233-1.527-6.108-4.132h-.27l-.628 4.491h-5.928v-63.955h7.365v17.426l-.18 7.905q2.965-2.605 6.468-4.312 3.593-1.796 7.186-1.796 8.533 0 12.935 6.018 4.401 6.018 4.401 16.168 0 7.455-2.694 12.755-2.605 5.3-6.917 8.084-4.222 2.785-9.252 2.785zm-1.258-6.198q5.39 0 8.893-4.58 3.593-4.672 3.593-12.756 0-7.186-2.695-11.587-2.605-4.491-8.803-4.491-2.784 0-5.659 1.527-2.874 1.527-6.018 4.401v22.905q2.875 2.515 5.66 3.593 2.874.988 5.03.988zM351.19 168.68v-43.655h6.108l.629 7.905h.27q2.245-4.132 5.479-6.558 3.233-2.425 6.916-2.425 2.605 0 4.671.898l-1.437 6.468q-1.078-.36-1.976-.54-.899-.179-2.246-.179-2.784 0-5.838 2.246-2.965 2.245-5.21 7.814v28.025zM390.26 169.76q-5.48 0-9.162-3.234-3.593-3.323-3.593-9.162 0-7.186 6.377-10.959 6.468-3.862 20.39-5.39 0-2.784-.808-5.299-.719-2.515-2.695-4.042-1.886-1.617-5.479-1.617-3.773 0-7.096 1.437-3.324 1.438-5.928 3.234l-2.875-5.12q3.054-1.976 7.456-3.773 4.49-1.886 9.7-1.886 7.995 0 11.588 4.94 3.593 4.851 3.593 13.026v26.768h-6.108l-.63-5.21h-.269q-3.054 2.515-6.736 4.401-3.593 1.886-7.725 1.886zm2.156-5.928q3.144 0 5.928-1.527 2.785-1.527 5.929-4.312v-12.126q-10.87 1.347-15.27 4.042-4.312 2.695-4.312 6.917 0 3.682 2.246 5.39 2.245 1.616 5.479 1.616zM425.47 168.68v-43.655h6.108l.629 7.905h.27q2.245-4.132 5.479-6.558 3.233-2.425 6.916-2.425 2.605 0 4.671.898l-1.437 6.468q-1.078-.36-1.976-.54-.898-.179-2.246-.179-2.784 0-5.838 2.246-2.965 2.245-5.21 7.814v28.025zM459.6 187.45q-1.437 0-2.785-.27-1.257-.269-2.335-.628l1.437-5.839q.719.18 1.617.36.898.269 1.707.269 3.683 0 6.108-2.695 2.425-2.605 3.772-6.647l.988-3.233-17.516-43.745h7.636l8.892 24.163q.988 2.784 2.066 6.018 1.168 3.233 2.156 6.287h.36q.987-2.964 1.886-6.197.898-3.234 1.796-6.109l7.815-24.163h7.186l-16.438 47.248q-1.527 4.312-3.683 7.725-2.066 3.414-5.21 5.39-3.054 2.066-7.455 2.066z"></path>
        </g>
        <g aria-label="Trusted evidence." fill="#1f3c73" stroke-width="3.368">
          <path d="M710.25 61.723V30.141h-10.671v-3.773h25.869v3.773h-10.671v31.582zM728.9 61.723V35.53h3.665l.377 4.743h.162q1.347-2.48 3.287-3.935t4.15-1.455q1.563 0 2.803.54l-.863 3.88q-.646-.216-1.185-.324-.54-.108-1.348-.108-1.67 0-3.503 1.348-1.778 1.347-3.126 4.689v16.815zM755.25 62.37q-4.15 0-6.09-2.587-1.94-2.64-1.94-7.653v-16.6h4.473v16.007q0 3.665 1.132 5.336 1.185 1.67 3.772 1.67 2.048 0 3.611-1.024 1.617-1.078 3.45-3.395V35.53h4.42v26.193h-3.666l-.377-4.096h-.162q-1.832 2.156-3.88 3.45-2.048 1.293-4.743 1.293zM783.76 62.37q-2.803 0-5.336-1.024-2.533-1.078-4.419-2.587l2.21-2.964q1.724 1.347 3.557 2.263 1.832.863 4.15.863 2.587 0 3.88-1.186 1.294-1.24 1.294-2.91 0-1.348-.917-2.264-.862-.916-2.263-1.509-1.348-.647-2.803-1.186-1.832-.7-3.61-1.562-1.78-.917-2.911-2.318-1.132-1.455-1.132-3.665 0-3.18 2.372-5.281 2.425-2.156 6.683-2.156 2.425 0 4.527.862t3.61 2.102l-2.155 2.802q-1.347-1.024-2.803-1.67-1.455-.647-3.18-.647-2.479 0-3.664 1.132-1.132 1.132-1.132 2.64 0 1.24.809 2.049.808.754 2.101 1.347 1.294.539 2.749 1.132 1.886.7 3.719 1.617 1.832.862 3.018 2.371 1.24 1.455 1.24 3.934 0 2.102-1.132 3.88-1.078 1.78-3.234 2.857-2.102 1.078-5.228 1.078zM806.67 62.37q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306V39.141h-3.88V35.8l4.095-.27.54-7.33h3.718v7.33h7.06v3.61h-7.06v14.553q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.509-.216l1.455-.485.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM826.5 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.071-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.562 2.91q-1.67 1.078-3.826 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM851.56 62.37q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V23.35h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61V41.35q-1.67-1.509-3.234-2.102-1.509-.646-3.126-.646-2.101 0-3.826 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.69 1.886 7.384 1.887 2.64 5.336 2.64zM893.92 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743t-1.67-7.33q0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.706 3.341 2.75 3.342 2.75 8.947 0 .7-.055 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.796.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.959 2.156-2.155 2.102-2.587 5.982zM915.97 61.723l-9.432-26.193h4.581l4.959 14.875 1.185 3.88q.647 1.94 1.24 3.827h.216q.592-1.886 1.185-3.827.647-1.94 1.186-3.88l4.958-14.875h4.366l-9.27 26.193zM935.48 61.723V35.53h4.42v26.193zm2.264-31.582q-1.294 0-2.156-.755-.809-.808-.809-2.155 0-1.294.809-2.102.862-.809 2.156-.809 1.293 0 2.101.809.863.808.863 2.102 0 1.347-.862 2.155-.809.755-2.102.755zM957.68 62.37q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V23.35h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61V41.35q-1.67-1.509-3.234-2.102-1.509-.646-3.126-.646-2.101 0-3.826 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.69 1.887 7.384 1.886 2.64 5.335 2.64zM989.26 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743t-1.67-7.33q0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM1005.4 61.723V35.53h3.665l.377 3.773h.162q1.886-1.887 3.988-3.126 2.102-1.294 4.797-1.294 4.15 0 6.036 2.641 1.94 2.587 1.94 7.6v16.6h-4.42V45.715q0-3.665-1.185-5.335t-3.773-1.671q-1.994 0-3.61 1.024-1.563 1.024-3.558 3.018v18.971zM1045.2 62.37q-3.45 0-6.252-1.617t-4.42-4.689q-1.616-3.072-1.616-7.383 0-4.42 1.725-7.492 1.778-3.072 4.635-4.688 2.91-1.617 6.251-1.617 2.587 0 4.42.916 1.886.916 3.233 2.156l-2.263 2.91q-1.132-1.024-2.425-1.67-1.24-.647-2.803-.647-2.371 0-4.258 1.293-1.832 1.24-2.91 3.557-1.024 2.264-1.024 5.282 0 4.473 2.21 7.276 2.263 2.748 5.874 2.748 1.833 0 3.396-.754 1.563-.809 2.748-1.887l1.94 2.965q-1.778 1.563-3.934 2.479-2.156.862-4.527.862zM1068.9 62.37q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.071-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.707 3.341 2.748 3.342 2.748 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.678q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.724-6.036-1.671-2.102-4.743-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM1087.4 62.37q-1.347 0-2.317-.916-.917-.97-.917-2.426 0-1.562.917-2.479.97-.97 2.317-.97 1.294 0 2.21.97.97.916.97 2.48 0 1.455-.97 2.425-.916.916-2.21.916z"></path>
        </g>
        <g aria-label="Informed decisions." fill="#1f3c73" stroke-width="3.368">
          <path d="M699.58 124.7V89.345h4.473V124.7zM713.32 124.7V98.507h3.665l.377 3.773h.162q1.886-1.887 3.988-3.126 2.102-1.294 4.797-1.294 4.15 0 6.036 2.641 1.94 2.587 1.94 7.6v16.6h-4.42v-16.008q0-3.665-1.185-5.335-1.186-1.671-3.773-1.671-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018V124.7zM743.56 124.7v-22.582h-3.557v-3.341l3.557-.27v-4.15q0-3.988 1.832-6.306 1.887-2.371 5.821-2.371 1.24 0 2.371.27 1.132.215 1.995.592l-.97 3.396q-1.456-.647-2.965-.647-3.665 0-3.665 5.066v4.15h5.552v3.61h-5.552V124.7zM768.19 125.35q-3.18 0-5.982-1.617-2.749-1.617-4.474-4.689-1.67-3.072-1.67-7.383 0-4.42 1.67-7.492 1.725-3.072 4.474-4.688 2.802-1.617 5.982-1.617 3.234 0 5.982 1.617 2.749 1.616 4.42 4.688 1.724 3.072 1.724 7.492 0 4.311-1.724 7.383-1.671 3.072-4.42 4.69t-5.982 1.616zm0-3.665q3.395 0 5.443-2.748 2.102-2.803 2.102-7.276 0-4.527-2.102-7.33-2.048-2.802-5.443-2.802-3.341 0-5.443 2.802t-2.102 7.33q0 4.473 2.102 7.276 2.102 2.748 5.443 2.748zM787.21 124.7V98.507h3.665l.377 4.743h.162q1.347-2.48 3.287-3.935t4.15-1.455q1.563 0 2.803.54l-.863 3.88q-.646-.216-1.185-.324-.54-.108-1.348-.108-1.67 0-3.503 1.348-1.778 1.347-3.126 4.689V124.7zM805.91 124.7V98.507h3.665l.377 3.773h.162q1.724-1.887 3.772-3.126 2.048-1.294 4.366-1.294 3.018 0 4.689 1.348 1.724 1.293 2.533 3.664 2.048-2.21 4.15-3.61 2.101-1.402 4.473-1.402 4.042 0 5.982 2.641 1.994 2.587 1.994 7.6v16.6h-4.42v-16.008q0-3.665-1.185-5.335-1.186-1.671-3.665-1.671-2.91 0-6.575 4.042V124.7h-4.42v-16.007q0-3.665-1.185-5.336-1.186-1.67-3.719-1.67-2.91 0-6.575 4.042v18.97zM861.21 125.35q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.071-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.562 2.91q-1.67 1.078-3.826 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.724-6.036-1.671-2.102-4.743-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM886.27 125.35q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V86.33h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61v-13.69q-1.67-1.509-3.234-2.102-1.509-.646-3.126-.646-2.101 0-3.826 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.689 1.886 7.384 1.887 2.64 5.336 2.64zM926.96 125.35q-4.904 0-7.869-3.557-2.964-3.61-2.964-10.132 0-4.258 1.563-7.33 1.617-3.126 4.204-4.796 2.64-1.671 5.605-1.671 2.264 0 3.934.808 1.671.809 3.396 2.21l-.216-4.473V86.33h4.473v38.373h-3.664l-.378-3.072h-.161q-1.51 1.509-3.557 2.64-2.048 1.079-4.366 1.079zm.97-3.719q3.45 0 6.683-3.61v-13.69q-1.67-1.509-3.234-2.102-1.509-.646-3.125-.646-2.102 0-3.827 1.293-1.67 1.24-2.695 3.503-1.024 2.21-1.024 5.228 0 4.689 1.887 7.384 1.886 2.64 5.335 2.64zM958.54 125.35q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743t-1.67-7.33q0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.959 2.156-2.155 2.102-2.587 5.982zM985.01 125.35q-3.45 0-6.252-1.617-2.802-1.617-4.42-4.689-1.616-3.072-1.616-7.383 0-4.42 1.725-7.492 1.778-3.072 4.635-4.688 2.91-1.617 6.251-1.617 2.587 0 4.42.916 1.886.916 3.233 2.156l-2.263 2.91q-1.132-1.024-2.425-1.67-1.24-.647-2.803-.647-2.371 0-4.258 1.293-1.832 1.24-2.91 3.557-1.024 2.264-1.024 5.282 0 4.473 2.21 7.276 2.263 2.748 5.874 2.748 1.833 0 3.396-.754 1.563-.809 2.748-1.887l1.94 2.965q-1.778 1.563-3.934 2.479-2.156.862-4.527.862zM999.23 124.7V98.507h4.42V124.7zm2.264-31.582q-1.294 0-2.156-.755-.809-.808-.809-2.155 0-1.294.809-2.102.862-.809 2.156-.809 1.293 0 2.101.809.863.808.863 2.102 0 1.347-.862 2.155-.809.755-2.102.755zM1019.3 125.35q-2.803 0-5.336-1.024-2.533-1.078-4.419-2.587l2.21-2.964q1.724 1.347 3.557 2.263 1.832.863 4.15.863 2.587 0 3.88-1.186 1.293-1.24 1.293-2.91 0-1.348-.916-2.264-.862-.916-2.263-1.509-1.348-.647-2.803-1.185-1.832-.701-3.61-1.563-1.78-.917-2.911-2.318-1.132-1.455-1.132-3.665 0-3.18 2.371-5.281 2.426-2.156 6.683-2.156 2.426 0 4.528.862 2.101.862 3.61 2.102l-2.155 2.803q-1.348-1.024-2.803-1.671-1.455-.647-3.18-.647-2.479 0-3.664 1.132-1.132 1.132-1.132 2.64 0 1.24.808 2.049.809.754 2.102 1.347 1.294.539 2.749 1.132 1.886.7 3.718 1.617 1.833.862 3.019 2.371 1.24 1.455 1.24 3.934 0 2.102-1.133 3.88-1.078 1.78-3.233 2.857-2.102 1.078-5.228 1.078zM1035.1 124.7V98.507h4.42V124.7zm2.264-31.582q-1.294 0-2.156-.755-.809-.808-.809-2.155 0-1.294.809-2.102.862-.809 2.156-.809t2.101.809q.863.808.863 2.102 0 1.347-.863 2.155-.808.755-2.101.755zM1058.5 125.35q-3.18 0-5.982-1.617-2.749-1.617-4.474-4.689-1.67-3.072-1.67-7.383 0-4.42 1.67-7.492 1.725-3.072 4.474-4.688 2.802-1.617 5.982-1.617 3.234 0 5.982 1.617 2.749 1.616 4.42 4.688 1.724 3.072 1.724 7.492 0 4.311-1.724 7.383-1.671 3.072-4.42 4.69-2.748 1.616-5.982 1.616zm0-3.665q3.395 0 5.443-2.748 2.102-2.803 2.102-7.276 0-4.527-2.102-7.33-2.048-2.802-5.443-2.802-3.341 0-5.443 2.802t-2.102 7.33q0 4.473 2.102 7.276 2.101 2.748 5.443 2.748zM1077.5 124.7V98.507h3.665l.377 3.773h.162q1.886-1.887 3.988-3.126 2.102-1.294 4.797-1.294 4.15 0 6.036 2.641 1.94 2.587 1.94 7.6v16.6h-4.42v-16.008q0-3.665-1.185-5.335-1.186-1.671-3.773-1.671-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018V124.7zM1113.9 125.35q-2.803 0-5.336-1.024-2.533-1.078-4.419-2.587l2.21-2.964q1.724 1.347 3.557 2.263 1.832.863 4.15.863 2.587 0 3.88-1.186 1.293-1.24 1.293-2.91 0-1.348-.916-2.264-.862-.916-2.263-1.509-1.348-.647-2.803-1.185-1.832-.701-3.61-1.563-1.78-.917-2.911-2.318-1.132-1.455-1.132-3.665 0-3.18 2.372-5.281 2.425-2.156 6.683-2.156 2.425 0 4.527.862 2.102.862 3.61 2.102l-2.155 2.803q-1.348-1.024-2.803-1.671-1.455-.647-3.18-.647-2.479 0-3.664 1.132-1.132 1.132-1.132 2.64 0 1.24.808 2.049.809.754 2.102 1.347 1.294.539 2.749 1.132 1.886.7 3.718 1.617 1.833.862 3.019 2.371 1.24 1.455 1.24 3.934 0 2.102-1.133 3.88-1.078 1.78-3.233 2.857-2.102 1.078-5.228 1.078zM1131.9 125.35q-1.347 0-2.317-.916-.917-.97-.917-2.426 0-1.562.917-2.479.97-.97 2.317-.97 1.294 0 2.21.97.97.916.97 2.48 0 1.455-.97 2.425-.916.916-2.21.916z"></path>
        </g>
        <g aria-label="Better health." fill="#a53995" stroke-width="3.368">
          <path d="M699.58 187.95v-35.355h10.509q3.61 0 6.306.862 2.748.863 4.257 2.749 1.563 1.886 1.563 5.012 0 2.64-1.347 4.797-1.294 2.102-3.827 2.91v.216q3.18.592 5.174 2.694 2.048 2.102 2.048 5.767 0 3.45-1.724 5.767-1.671 2.317-4.69 3.449-3.017 1.132-7.005 1.132zm4.473-20.318h5.228q4.527 0 6.521-1.563 1.994-1.563 1.994-4.258 0-3.072-2.101-4.365-2.048-1.294-6.198-1.294h-5.444zm0 16.761h6.144q4.581 0 7.114-1.67 2.533-1.725 2.533-5.282 0-3.288-2.533-4.797-2.479-1.563-7.114-1.563h-6.144zM741.46 188.6q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.072-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.706 3.341 2.75 3.342 2.75 8.947 0 .7-.055 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.796.808zm-8.246-15.845h14.013q0-3.988-1.724-6.036-1.671-2.102-4.743-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM765.28 188.6q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306v-14.498h-3.88v-3.341l4.095-.27.54-7.33h3.718v7.33h7.06v3.611h-7.06v14.552q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.51-.215l1.454-.486.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM782.42 188.6q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306v-14.498h-3.88v-3.341l4.095-.27.54-7.33h3.718v7.33h7.06v3.611h-7.06v14.552q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.51-.215l1.454-.486.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM802.25 188.6q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.072-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.658-1.67 5.013 0 7.707 3.341 2.749 3.342 2.749 8.947 0 .7-.054 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.616-.593 3.072-1.509l1.562 2.91q-1.67 1.078-3.826 1.887-2.102.808-4.797.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.958 2.156-2.156 2.102-2.587 5.982zM818.36 187.95v-26.193h3.665l.377 4.743h.162q1.347-2.48 3.287-3.935t4.15-1.455q1.563 0 2.803.54l-.863 3.88q-.646-.216-1.185-.324t-1.348-.108q-1.67 0-3.503 1.348-1.778 1.347-3.126 4.689v16.815zM847.84 187.95v-38.373h4.42v10.456l-.162 5.39q1.886-1.779 3.934-3.019 2.102-1.293 4.797-1.293 4.15 0 6.036 2.64 1.94 2.588 1.94 7.6v16.6h-4.42v-16.007q0-3.665-1.185-5.336-1.186-1.67-3.773-1.67-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018v18.97zM887.78 188.6q-3.503 0-6.36-1.617-2.856-1.67-4.527-4.743-1.67-3.072-1.67-7.33 0-4.31 1.67-7.383 1.725-3.072 4.42-4.743 2.694-1.67 5.659-1.67 5.012 0 7.706 3.341 2.75 3.342 2.75 8.947 0 .7-.055 1.401 0 .647-.108 1.132h-17.677q.27 4.15 2.587 6.629 2.372 2.48 6.144 2.48 1.887 0 3.45-.54 1.617-.593 3.072-1.509l1.563 2.91q-1.671 1.078-3.827 1.887-2.102.808-4.796.808zm-8.246-15.845h14.013q0-3.988-1.725-6.036-1.67-2.102-4.742-2.102-2.749 0-4.959 2.156-2.155 2.102-2.586 5.982zM909.18 188.6q-3.288 0-5.497-1.94-2.156-1.994-2.156-5.498 0-4.311 3.826-6.575 3.88-2.317 12.234-3.233 0-1.671-.485-3.18-.43-1.51-1.616-2.426-1.132-.97-3.288-.97-2.264 0-4.258.863-1.994.862-3.557 1.94l-1.724-3.072q1.832-1.186 4.473-2.264 2.695-1.131 5.82-1.131 4.797 0 6.953 2.964 2.156 2.91 2.156 7.814v16.061h-3.665l-.377-3.125h-.162q-1.832 1.509-4.042 2.64-2.156 1.132-4.635 1.132zm1.294-3.557q1.886 0 3.556-.916 1.671-.916 3.557-2.587v-7.276q-6.52.808-9.162 2.425-2.587 1.617-2.587 4.15 0 2.21 1.348 3.234 1.347.97 3.287.97zM934.99 188.6q-2.48 0-3.61-1.509-1.079-1.563-1.079-4.42v-33.09h4.42v33.415q0 1.024.377 1.509.377.43.862.43h.377q.216-.053.593-.107l.593 3.341q-.431.216-1.024.324-.593.108-1.509.108zM952.29 188.6q-4.204 0-5.875-2.425-1.616-2.426-1.616-6.306v-14.498h-3.88v-3.341l4.095-.27.54-7.33h3.718v7.33h7.06v3.611h-7.06v14.552q0 2.425.862 3.773.916 1.293 3.18 1.293.7 0 1.51-.215l1.454-.486.863 3.342q-1.078.377-2.372.647-1.24.323-2.479.323zM962.26 187.95v-38.373h4.42v10.456l-.162 5.39q1.886-1.779 3.934-3.019 2.102-1.293 4.797-1.293 4.15 0 6.036 2.64 1.94 2.588 1.94 7.6v16.6h-4.42v-16.007q0-3.665-1.185-5.336-1.186-1.67-3.773-1.67-1.994 0-3.61 1.024-1.564 1.024-3.558 3.018v18.97zM993.9 188.6q-1.347 0-2.317-.916-.917-.97-.917-2.426 0-1.563.916-2.479.97-.97 2.318-.97 1.294 0 2.21.97.97.917.97 2.48 0 1.455-.97 2.425-.917.916-2.21.916z"></path>
        </g>
      </svg>
    </div>
    <h1>Supplementary material 28 to: Daily iron supplementation for prevention or treatment of iron deficiency anaemia in infants, children, and adolescents</h1>
    <p>
      <span class="byline">Rajagopalan K, Hackl L, Pe&ntilde;a-Rosas JP, Garcia-Casal MN, Rizal M, Mehta NH, Roudik M, Islam S, Trumbull-Kennedy MM, Khondakar NR, Franco JVA, Finkelstein JL, Mehta S</span>
      <br>
      <span class="doi"><a href="https://doi.org/10.1002/14651858.CD013227.pub2">https://doi.org/10.1002/14651858.CD013227.pub2</a></span>
    </p>
    <p>
      <span class="disclaimer">The material in this section has been supplied by the author(s) for publication under a Licence for Publication and the author(s) are solely responsible for the material. Cochrane has reviewed this material, but Cochrane has not copyedited, formatted or proofread. Cochrane accordingly gives no representations or warranties of any kind in relation to, and accepts no liability for any reliance on or use of, such material.</span>
    </p>
    <div id="backToTop">
      <a href="#top">Back to top</a>
    </div>
    <h1>Description of interventions_4</h1>
    <div>
      <table>
        <tr>
          <th style="vertical-align: top;">
            <p>Item</p>
          </th><th style="vertical-align: top;">
            <p>Study ID</p>
          </th>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td style="vertical-align: top;">
            <p>Engstrom 2008</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Effectiveness of daily and weekly iron supplementation in the prevention of anemia in infants"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...children aged six months"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"To evaluate the effectiveness of universal prophylactic targeting with iron sulfate on daily or weekly basis in the prevention of anemia in infants."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"The second part of the intervention consisted of an educational component, administered during the recruitment visit, and which included two items: a booklet for mothers addressing the causes, consequences, and means of prevention of anemia, as well as orientation on the use of SSFARM [ferrous sulphate syrup], and a calendar for recording all doses administered to the child....Health care ... were given scientific material providing information on the clinical and epidemiological aspects of anemia and the nature of the proposed intervention."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Data collection was identical for all three groups. Prior to the final evaluation, identification data and weight at six months were extracted from the child&rsquo;s health records. During this evaluation, trained researchers administered a semi-structured questionnaire aimed at characterizing the children and their families and evaluating the intervention, measured the child&rsquo;s weight and length, and collected a blood sample for hemoglobin (Hb) quantification. The questionnaire included questions on sociodemographic variables and on the living conditions of families, birth-related variables, and history of morbidity. In addition, we also collected information on dietary history and pattern at age 12 months (using a 24-hour recall).</p>
            <p> 
            </p>
            <p>Hb levels were quantified in heel-prick blood samples using the Hemocue&reg; system. Prevalence of anemia was estimated using an Hb&lt;110.0 g/l cutoff.23Weight and height were measured by standardized interviewers, using internationally recommended techniques.[<a href="#422225289933754918">1</a>]</p>
            <p> 
            </p>
            <p>Weight was obtained with the child naked, using a Tanita&reg; portable digital scale with 100 g precision. Length was measured using a wooden horizontal anthropometer to which was attached a tape measure with millimeter precision. In all cases, three measures of length were taken, with the mean being used for all analyses. Nutritional status was classified as under-weight or overweight24 based on information extracted from the child&rsquo;s medical records (for six months) or by direct measurement (at 12 months)...We used EpiInfo (6.04) software for sample size and power calculations, data entry, and calculation of anthropometric indicators. Remaining analyses were carried out using Stata software v.9.0, taking into account cluster sampling."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Health care professionals were trained to deliver the intervention and were given scientific material providing information on the clinical and epidemiological aspects of anemia and the nature of the proposed intervention. Child follow-up during the intervention was done ac-cording to the routine procedures of each PHU...trained researchers administered a semi-structured questionnaire" </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...provide mothers with vials of FS syrup during routine follow-up visits accompanied by the instruction to administer the product"<br>  
              <br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...primary healthcare units...in the city of Rio de Janeiro, Brazil...PHU with a monthly clientele of at least 60 children under 1 year of age and which used a computerized management information system. We identified 28 PHU that fulfilled these conditions. Of these, we randomly selected three units each for DG and WG, and nine for CG."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...provide mothers with vials of FS syrup during routine follow-up visits carried out when babies reached the age of six months...to administer the product to the child in a preventive manner, either every day (DG) or one day per week (WG), for 24 weeks, until he or she completed 12 months of age...The ferrous sulfate syrup used (SSFARM) contained 5 mg/ml ferrous sulfate....produced...by Farmanguinhos/Fiocruz...corresponded to 12.5 mg iron (2.5ml) per day (2.5 ml) for DG and 25 mg iron (5.0 ml) per week for WG."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"The third cohort (control group &ndash; CG)...In order to prevent any contact between the research team and these children before 12 months of age, recruitment of subjects into this group was done retrospectively....All children with anemia at the end of the study were treated with FS using the therapeutic dosage (3-4 mg iron/kg/day)."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>&mdash;<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"The second part of the intervention consisted of an educational component, administered during the recruitment visit, and which included two items: a booklet for mothers addressing the causes, consequences, and means of prevention of anemia, as well as orientation on the use of SSFARM, and a calendar for recording all doses administered to the child...To reduce potential losses at this point, we resorted to contacting mothers by aerogram, telephone, and home visits."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"One hundred and eighty-eight children were selected for DG and 188 for WG; of these, we were able to evaluate 150 and 147, respectively (roughly 80% of selected children). Losses were similar in both groups, and were due mostly to problems in locating subjects&rsquo; homes, especially in slum areas, and to changes of address."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td style="vertical-align: top;">
            <p>Fallahi 2007</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td style="vertical-align: top;">
            <p>Iron and zinc supplementation in primary school children</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td style="vertical-align: top;">
            <p>Primary school children in fifth grade</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td style="vertical-align: top;">
            <p>"to investigate the effects of supplementation of iron and zine, alone or combined, on iron, zinc and vitamin A status in primary school children."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td style="vertical-align: top;">
            <p>"Children in each of the 3 groups received 1 capsule day<sup>-1</sup> of a powder containing 20 mg Fe as ferrous sulfate, 20 mg Zn as zine sulfate, or 20 mg Fe plus 20 mg Zn."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td style="vertical-align: top;">
            <p>"Food consumption survey was carried out by one 24 h recall and two days record of foodstuffs (2-week day and 1 weekend) for each subject."...</p>
            <p>"An 8-mI sample of fasting venous blood was collected from each child at baseline and after 4mo of supplementation. After separating the needle, 2mL of the blood was poured in an acid-washed tube for serum zinc measurement by flame atomic absorption spectrophotometer. The remaining blood was transferred to a mineral-free evacuated tube and keep in an acid-washed tube containing 5% EDTA as an anticoagulant. Hemoglobin (Hb) was measured within<br> 3 h (Coulter Electronic, Cobas micros). Plasma was separated by centrifugation at 1000&times;g for 10min at 20&deg;C. Portions of plasma and s e r u m were frozen immediatelv and maintained at -70&deg;C until analyzed. Plasma ferritin was measured by radioimmunoassay method. Plasma retinol was measured by HPLC method (Zanuto et al., 2003). C-reactive protein (CRP) was measured with the Chem. Enzyme-CRP kit (Tehran, Iran)."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td style="vertical-align: top;">
            <p>field worker visited the school and provided the supplement </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td style="vertical-align: top;">
            <p>individual</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td style="vertical-align: top;">
            <p>school</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td style="vertical-align: top;">
            <p>Iron group: 20 mg/d Fe as ferrous sulfate in a capsule; Zinc group: 20 mg/d Zn as zinc sulfate as a capsule, Iron+Zinc group: 20 mg/d Fe plus 20 mg Zn/d as a capsule</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"Children in each group were visited at school from Saturday through Thursday each week by the field worker who gave the capsule to each child and ensured that ti was consumedcompletely. Only one child dropped out of the study before the end of the 4 months."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td style="vertical-align: top;">
            <p>Fahmida 2007</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td style="vertical-align: top;">
            <p>Iron and Zinc supplementation for improved linear growth in infants</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td style="vertical-align: top;">
            <p>infants "aged 3-6 months old at enrollment, predominantly breast-fed, and free from apparent congenital abnormalities"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td style="vertical-align: top;">
            <p>"In area where stunting prevalence is high zinc supple- mentation is expected to improve linear growth; however the effect may be variable depending on whether zinc is the limiting or problem nutrient and on whether deficiencies in other nutrients which may limit a growth response to zinc supplementations exist.3 While zinc and iron share common food sources, high dose of zinc can potentially induce antagonistic interactions with iron.4 Vitamin A has also been shown to have specific benefit on linear growth i.e. on children with vitamin A deficiency.5 Studies with zinc supplementation often only include parameter on zinc status and hence miss the information on how other nutri- ents status affected growth."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td style="vertical-align: top;">
            <p>"Weight and length were measured at baseline and monthly during six month supplementation by trained nutritionist using standard methods.8 Weight was measured to the nearest 0.1kg with the child minimally clothed using an electronic weighing scale (SECA 770). Recumbent length was recorded to the nearest 0.1cm using a wooden length board (SEAMEO TROPMED). In addition, anthropometric measurements were also performed six months after the end of supplementation. Eight field workers (nutritionists and nurse) were trained and standardized by one of the authors (UF) to take all of the anthropometric measurements. Four persons with the highest precision and accuracy on length measurement which met the required standard were assigned as the nutritionist whereas the other four persons helped in holding the subjects for length measurements. Non-fasting blood samples were collected between 0700 and 1200. About 3-5 ml whole blood was withdrawn and put into acid-wash vacutainers, immediately stored in cool box prior to separation. Serum was separated by centrifugation at 2500 rpm for 10 min at room temperature. Serum samples were put into separate vials for assessment of serum zinc (in acid-washed vial), serum ferritin and serum retinol (non acid-washed vials). The vials were stored at -300C until analysis.<br> Serum zinc was analyzed with flame atomic absorption</p>
            <p>spectrophotometry at Nutrition Research Development Center laboratory. Serum ferritin was determined with enzyme-linked immunoassay (ELISA) and serum retinol with high pressure liquid spectroscopy (HPLC) at the SEAMEO-TROPMED University of Indonesia laboratory. Between-duplicate variability were &lt;5% for all biochemical analyses (serum zinc, ferritin, and retinol).</p>
            <p>Haemoglobin samples were collected using filter paper methods of blood samples obtained from heel-prick and were analyzed by standard cyanmethemoglobin method.10</p>
            <p>Information on complementary feeding and breastfeeding was obtained at baseline and every month using single 24hour-recall with mothers (or main caregivers). Since subjects started the study at different ages (3-6 months) dietary analyses was performed for intakes at 6-9 month of age in which all infants had the data. World Food 2 program (University of California, Davis) was used to calculate nutrient intake from complementary foods."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td style="vertical-align: top;">
            <p>"Every subject received a personal bottle with a dosing syringe, labeled with the subject&rsquo;s name and code (the code indicated the location and the responsible cadre as well). The bottles were kept safe by the health volunteer who gave the supplements (2 mL syrup/day) for 30 days per month by door-to-door visits to the subjects&rsquo; houses."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td style="vertical-align: top;">
            <p>Intervention was provided daily in the form of ferrous sulphate in a syrup. </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td style="vertical-align: top;">
            <p>"East Lombok district, West Nusa Tenggara province, Indonesia"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td style="vertical-align: top;">
            <p>"There were four supplementation groups in the study: zinc alone (10 mg/d), iron and zinc (10 mg of each/day), iron, zinc, and vitamin A (10 mg/day of each iron and zinc and 1,000 IU/d vitamin-A), and placebo. Zinc and iron were given as <i>zinc sulfate </i>and <i>ferrous sulfate, </i>while vitamin-A as <i>retinol-acetate."</i>
            </p>
            <p>..."The bottles were kept safe by the health volunteer who gave the supplements (2 mL syrup/day) for 30 days per month...<i>"</i>
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"The cadres recorded subjects&rsquo; compliance in compliance forms i.e. whether subjects took the syrup/not and if not why, also on any side effects reported by the mothers. Every month the field coordinators distributed new bottles to cadres according to the list of subjects&rsquo; allocation to the supplements&rsquo; codes. The bottle was labeled with the sub- ject&rsquo;s name and weighed to estimate bottle+syrup weight. After the 30th day the bottles were collected and weighed. The difference between bottle+syrup before and after dis- tribution for each subject was used as an estimate of syrup consumed by the subject and was converted to days of compliance i.e. days of compliance = (syrup weight : weight per ml): 2 mL/day. Compliance was calculated as days of compliance divided by 180 days of intervention times 100%. Compliance based on bottle weighing was used as reference whereas compliance based on the cad- res&rsquo; record was used to cross-check the compliance data from bottle weighing."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"Median [range] of the overall compliance was 97% [range: 52-100%] and did not differ between the four groups."</p>
          </td>
        </tr>
        <tr>
          <td colspan="2" style="vertical-align: top;">
            <p>
              <b>CAT</b>:<b> </b>Cognitive Abilities Test; <b>CAT SD</b>: <b> </b>Cognitive Abilities Test, Stimulus Discrimination; <b>d</b>: day(s); <b>HAZ</b>: height-for-age Z-scores; <b>Hb</b>: haemoglobin;<b> LAZ</b>: length-for-age Z-scores; <b>MAT</b>: Math Achievement Test;<b> mo</b>: month(s);<b> PPVT</b>: Peabody Picture Vocabulary Test;<b> SES</b>: socio-economic status; <b>SF</b>: serum ferritin; <b>SSFARM</b>: ferrous sulphate syrup; <b>SZn</b>: serum zinc; <b>WAZ</b>: weight-for-age Z-scores; <b>WHZ</b>: weight-for-height Z-scores; <b>WISC-RM</b>: <b> </b>Wechsler Intelligence Scale for Children-Revised; <b>wk</b>: week(s); <b>WLZ</b>: weight-for-length Z-scores.</p>
            <p>&mdash;: denotes not reported</p>
          </td>
        </tr>
      </table>
    </div>
    <div>
      <table>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td style="vertical-align: top;">
            <p>Wasantwisut 2006</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>Iron and zinc supplementation among breastfed infants in rural Thailand </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"609 Thai infants aged 4&ndash;6 mo"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"to test the hypothesis that supplementation of iron or zinc alone, or iron and zinc combined, can improve iron and zinc status and growth of infants 4&ndash;6 mo of age compared with infants receiving a placebo. The interactions between iron and zinc on iron and zinc status indicators were also examined." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Lists of infants aged &lt;6 mo were obtained from the local health personnel and village health volunteers. When eligible infants reached the age of 4&ndash;6 mo, a verbal informed consent was obtained from the mothers or caretakers. The same information about the project was explained a second time and the verbal informed consent verified...Vitamin A drops at a dose of 1500 <i></i>g retinol equivalent (RE) were given to each subject at the beginning of the study."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"A culturally appropriate questionnaire, which included socio-economic status, household income, maternal age, weight, height, and medicinal supplements that mothers gave to their infants during the month prior to the intervention, was completed by the mothers at enrollment. Once each month, the research data collection team visited the field area. Data on the infant's health and feeding practices (breast-feeding frequency and intake of complementary food) were also collected...morbidity records from the village health volunteers were verified with the mother by one of the investigators. When applicable, morbidity was also verified with the health card at the health centers or district hospital...</p>
            <p> 
            </p>
            <p>Anthropometric measurements were performed on each infant using standard procedures [<a href="#422061599901842119">2</a>]. The child's body weight (wearing light clothing) was measured to the nearest 5 g using a portable beam balance (Detecto Infant Scale). Recumbent length was measured to the nearest 0.1 cm using a length of wooden board with a sliding foot piece. Anthropometry was assessed every 2 mo by 2 field researchers who were standardized periodically during the data collection...Two readings were taken at each measurement. For all infants, LAZ, weight-for-age Z-scores (WAZ), and weight-for-length Z-scores (WLZ) were calculated (EpiInfo 6.02) and based on the National Center for Health Statistics of 1977 [<a href="#422223210491677505">3</a>]. Birth weight data were retrieved from the baby's health card...Gestational age was estimated by recalling the last menstrual period and the completed weeks of gestation were recorded. Once a woman was suspected of being pregnant by the village health volunteers, she was invited to meet with the research team at monthly field visits to obtain the earliest possible recall of the last menstrual period...</p>
            <p> 
            </p>
            <p>A blood sample was taken from a subset of infants (whose mothers agreed to blood collection) at baseline and the end of the 6-mo supplementation period. Nonfasting blood samples were taken at 800 and 1400 h. Three mL of blood was obtained from the antecubital vein, using regular syringes. Random samples of syringes from each batch were tested for contamination by iron and zinc and were found to be uncontaminated. All glassware, plasticware, and microcontainer tubes were acid-washed. One mL of blood was put in a tube containing the anticoagulant, EDTA, and 2 mL were allowed to clot and then were centrifuged for serum.</p>
            <p>Blood samples were stored in a cool box immediately after the blood was taken. Separation of serum was done at the hospital laboratory and completed by 1500 of each field visit day. Samples were frozen at &minus;20&deg;C prior to analyses for zinc and ferritin. Hemoglobin was determined by the cyanmethemoglobin method [<a href="#422223252774718276">4</a>], and serum ferritin by enzyme-linked immunoassay [<a href="#422223298674559813">5</a>, <a href="#422223326842719047">6</a>] using the ES-33 system (Boehringer Mannheim). Serum zinc was measured by graphite furnace atomic absorption spectrophotometry (WL 213.9, current 15 mA and slit high 0.7) [<a href="#422223350497282961">7</a>]. For both ferritin and zinc, the initial and final samples were analyzed in the same batch. Certified reference materials were used for Hb, serum ferritin, and zinc. CBC-8 hematology controls (from R&amp;D Systems) were used for quality control of Hb"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Lists of infants...from the local health personnel and village health volunteers... The village health volunteers were trained and visited each family 2&ndash;3 times/wk to identify problems associated with the ingestion of the supplement, to encourage mothers to administer the supplements, and to keep a record of infants' illness (symptoms). Every week, 4 field workers were assigned to visit each village to check on each mother and to assist village health volunteers in monitoring the compliance and morbidity data. Supplement compliance...records were reviewed weekly by field workers."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>individual supplementation (home-based administration)</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"3 rural districts of Khon-Kaen Province, located &sim;450 km northeast of Bangkok" </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Supplements were made by PT Kenrose as a syrup and supplied by UNICEF of Indonesia...</p>
            <p>The syrup contained either 5 g/L (89.5 mmol/L) iron (as ferrous sulfate),</p>
            <p>5 g/L (76.5 mmol/L) zinc (as zinc sulfate),</p>
            <p>or both iron and zinc in the same concentrations.</p>
            <p>The 4 types of supplements were indistinguishable in appearance, color, taste, or odor. All supplements contained vitamin C (15 g/L).</p>
            <p>Vitamin A drops at a dose of 1500 <i></i>g retinol equivalent (RE) were given to each subject at the beginning of the study...Mothers were carefully instructed, in the presence of village health volunteers from respective communities, to administer the supplement using an oral medication syringe (2 mL/dose, equivalent to 10 mg of iron or zinc/d). Supplements were given between meals to avoid interference from the absorption of food. The supplement was given daily for a duration of 6 mo." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>&mdash;<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>&mdash;<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Each mother was provided with 2 bottles of syrup and a calendar to record each time she administered the syrup...The village health volunteers were trained and visited each family 2&ndash;3 times/wk to identify problems associated with the ingestion of the supplement, to encourage mothers to administer the supplements, and to keep a record of infants' illness (symptoms). Every week, 4 field workers were assigned to visit each village to check on each mother and to assist village health volunteers in monitoring the compliance and morbidity data. Supplement compliance was recorded by mothers or village health volunteers onto a monthly calendar provided with each supplement bottle. These records were reviewed weekly by field workers. At the monthly field visit, the research team measured the leftover syrup collected by the village health volunteers and dispensed new bottles to be distributed to the mothers."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"In total, 609 infants completed the study and were included in the analysis. There were 9, 13, 24, and 19 infants from the placebo, iron, zinc, and iron plus zinc groups, respectively, who did not complete the study...Reasons for dropout during the study included health problems (<i>n</i> = 2), moving (<i>n</i> = 49), and side effects attributed to the supplements (severe diarrhea, <i>n</i> = 3). Infants whose mothers introduced bottle feeding during the study (<i>n</i> = 4) and those not cooperative (<i>n</i> = 5) were excluded from the analysis. Infants not completing the study did not differ from those who completed the study in any of the characteristics at baseline." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td style="vertical-align: top;">
            <p>Tielsch 2006</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td style="vertical-align: top;">
            <p>"Effect of routine prophylactic supplementation with iron and folic acid on preschool child mortality in southern Nepal: community-based, cluster-randomised, placebo-controlled trial"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td style="vertical-align: top;">
            <p>"children 1&ndash;36 months of age who lived in households in the NNIPS catchment area of 30 Village Development Committees (VDCs; formerly called panchayats) in Sarlahi District along the border with Bihar State in northern India...The participating VDCs are similar to others in the district with a predominance of traditional, rural, Hindu culture."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td style="vertical-align: top;">
            <p>"Iron deficiency is widespread in the developing world and is especially common in young children who live on the Indian subcontinent. Supplementation with iron and folic acid alleviates severe anaemia and enhances neurodevelopment in deficient populations, but little is known about the risks of mortality and morbidity associated with supplementation."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td style="vertical-align: top;">
            <p>"We obtained oral informed consent on a community basis during meetings with community leaders. We also obtained verbal informed consent at the household level from the parents of eligible children. Occasionally, parents who initially refused to allow their children to be enrolled changed their minds during the follow-up phase of the study."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td style="vertical-align: top;">
            <p>"Community-level data on the presence of economic, education, and health facilities were obtained in interviews with community leaders done just before the start of enrolment. Household-level data on socioeconomic status, health indicators, household structure, and housing material were obtained during the full population census also done before enrolment. All households that entered the trial for the first time because of a recent birth had their household interview at the time of child enrolment...staff assessed compliance every week during their biweekly dosing and vital status assessment visits. The total number of tablets consumed by the child in the preceding week was recorded for every child. Investigators, study staff, and participants were unaware of assigned treatments. The Department of Child and Adolescent Health and Development at WHO, Geneva, Switzerland, kept the treatment assignment codes.</p>
            <p>To confirm that the supplements used were active, we selected and tested the iron and zinc status of a sample of children aged 24 months or older after 12 months of follow-up. A blood sample was taken from participating children and the haemoglobin concentration measured with the HemoCue haemoglobinometer (HemoCue, Angelhom, Sweden). The remaining blood was centrifuged and the serum separated, collected, stored at &minus;10&deg;C in Nepal, and then shipped in liquid nitrogen to Baltimore, MD, USA, where it was stored at &minus;70&deg;C until analysis was undertaken. Serum ferritin was assessed with an ELISA assay (DELFIA system by Wallac, Gaithersburg, MD, USA)...</p>
            <p>The community workers recorded any deaths during their weekly visits to the participating families. The causes of death were determined by two physicians by independent review of information obtained by verbal autopsy with members of the immediate family after an appropriate period of mourning. If there was disagreement about the cause of death, a consensus meeting was held...</p>
            <p> 
            </p>
            <p>Children in the morbidity subsamples were visited weekly. Mothers were asked about the onset and length of specific signs and symptoms for every day of the preceding week. The morbidities assessed included cough, fever, difficult or rapid breathing, diarrhoea, and dysentery. Visits to health-care providers in the previous week were also recorded. We diagnosed diarrhoea in individuals who produced four or more loose watery stools per day for one or more consecutive days, and persistent diarrhoea in those with watery stools for longer than 14 days. We defined dysentery as diarrhoea with blood or mucus in the stool on at least 1 day. We separated episodes of diarrhoea and dysentery by at least 3 symptom-free days. We diagnosed acute respiratory infection as one or more consecutive days of fever, cough, and difficulty breathing (all three symptoms had to be present on at least 1 day during the episode) with a minimum of 7 days between episodes."</p>
            <p> 
            </p>
            <p>"Motor and language milestone instruments were adapted for the local setting from previous work in another low-resource setting [<a href="#422223894286437548">8</a>] that drew from the Griffiths Mental Development Scale [<a href="#422244973844653841">9</a>] and the MacArthur Communicative Development Inventory [<a href="#422244999498065708">10</a>]. The motor milestone instrument included only those items correlated with the onset of bipedal locomotion, as identified through factor analysis of the original tool. Language milestones also were modified to include items from the Child Development Inventory [<a href="#422245017958770592">11</a>]. Trained fieldworkers visited homes every 3 mo and asked the mothers to report on whether the child could perform any of 29 motor and 20 language tasks specified in the milestone instrument. Five tasks on the motor scale had to be demonstrated by the child in the presence of the fieldworker before receiving a yes response. Fieldworkers stopped asking questions on each scale once five consecutive no responses were given. The motor and language milestone tasks achieved were ordered by the expected chronology of development. The milestone score was based on what parents reported as the most advanced task the child could perform by that visit (i.e., highest numerically ordered task at that visit). Thus, the motor and language scores could range from 0 to 29 and 0 to 20, respectively."</p>
            <p>
              <br> "Child temperament was assessed by the caregiver using a scale adapted from the temperament component of the Infant Characteristics Questionnaire [<a href="#422245040855213986">12</a>]. The adapted scale is a twelve-item instrument that includes eleven yes or no questions and a summary question asking about the relative ease or difficulty in caring for the child (easier than average, average or more difficult than average). Temperament questions focused on topics such as intensity of crying, mood, irritability, need for attention, fussiness, and independence. For each question, one point was associated with a poor temperament while zero points were awarded for good temperament. The summary three-category question was dichotomized such that children characterized as &ldquo;more difficult than average&rdquo; received one point, while children characterized as &ldquo;average&rdquo; or &ldquo;easier than average&rdquo; received zero points. The temperament scale was constructed by summing the 12 questions. Temperament scores could range from 0 to 12, with lower scores indicating easier temperament.<br> The eating behavior questionnaire consisted of nine commonly used questions about behaviors while eating and appetite. Some examples include the relative amount of eating for age, happiness during eating, and frequency with which the infant requested food. The first eight questions had yes or no response options. One point was awarded to indicate poor eating behaviors, while no points indicated better eating behaviors. The ninth question, assessing the relative quality of the child&rsquo;s appetite, had three response categories (good, average and poor). No points were awarded for the categories &ldquo;good&rdquo; and &ldquo;average,&rdquo; while &ldquo;poor&rdquo; appetite was awarded one point. The scores from each question were summed to create the composite eating behavior scale. Eating behavior scores could range from 0 to 9, with lower scores indicating better eating behaviors."<br> "Cognitive development was evaluated using the information-processing measures that were part of the FTII [<a href="#422245055895725988">13</a>] and the A-not-B Task [<a href="#422245093366065063">14</a>, <a href="#422245120936273834">15</a>]. Children were scheduled for the FTII and the A-not-B Task at the same time during a two-week window around 39 and 52 weeks, assuming term delivery. Only children aged 53 weeks, or less at baseline were eligible for these assessments. The tests were administered in mid-morning in the field office the A not - B Task before the FTII. Three local fieldworkers achieved at least 85 % on inter-rater reliability after being trained to conduct the tests. The FTII, a paired - comparison test, measures the span of time an infant views a familiar stimulus, identifies it as familiar, and shifts his attention to novel stimulus (27,30) {ref9}. The FTII generates the preference for novelty score-time spent looking at the novel stimuli divided by the time spent looking at both novel and familiar stimuli, a computation that the program calculates automatically. An other measure fixation duration was defined as time spent attending to the stimuli and was indicative of information - processing time. Fixation duration was calculated by dividing the sum of the time spent looking at the left stimulus by the sum of time spent looking at the right stimulus. These data are automatically generated by the FTII program. A faster processing time is indicative of more advanced development. The A-not-B Task measures the ability of an infant to recognize objects as being permanent and separate from the child (29). The concept of object permanence was described by Piaget as being one of the infant's most important accomplishments (30). In the A-not-B Task, a toy is hidden in one of two wells of the test apparatus, and the child is tasked to find it. To ensure that the challenge is age-appropriate, a time-delay may be imposed by the tester between hiding the toy and allowing the child to reach for it. In this study, the testers administered 1-3-second delay at all ages that increased by two seconds after the first three correct trials for 3-5 seconds.<br> "Because children first enrolling in the study could be 1&ndash;35 mo of age, the analysis was confined to those who had not yet started walking unassisted. Chi-square tests were used to compare distributions of adherence to supplement use. The mean difference in age at which children first walked unassisted between each supplement and placebo group and the relative risk of not yet walking unassisted by 18 mo was calculated with placebo as the reference. This cutpoint was used because it represents the 99th percentile of the upper end of the distribution for normal children, where one might expect a health impact of such extreme delayed milestone attainment [<a href="#422245178669295537">16</a>]."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td style="vertical-align: top;">
            <p>"On an individual level, study staff visited the children twice a week. They gave them a tablet directly and left enough tablets with the child's mother or caregiver to cover the daily doses until the next visit...community workers recorded any deaths"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td style="vertical-align: top;">
            <p>"...individual level"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td style="vertical-align: top;">
            <p>home-based administration</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td style="vertical-align: top;">
            <p>"...one tablet daily (or half a tablet if &lt;1 year old), containing: iron (12&middot;5 mg) and folic acid (50 g), iron and folic acid plus zinc, or placebo. The sweet, vanilla flavoured supplements were specially formulated and manufactured as dispersible tablets by Nutriset (Malaunay, France) in conjunction with the Department of Child and Adolescent Health and Development at WHO, and were packaged in blister packs of seven tablets...All children older than 6 months also received vitamin A as part of a national programme or, if missed, by study staff: those aged 12 months or older were given 200000 IU of vitamin A every 6 months and those aged 6&ndash;12 months were given 100000 IU."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td style="vertical-align: top;">
            <p>"All children older than 6 months also received vitamin A as part of a national programme or, if missed, by study staff: those aged 12 months or older were given 200000 IU of vitamin A every 6 months and those aged 6&ndash;12 months were given 100000 IU...Older children usually ate the tablet directly and mothers were instructed to dissolve the tablet in clean water or breastmilk for younger children."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"On an individual level, study staff visited the children twice a week. They gave them a tablet directly and left enough tablets with the child's mother or caregiver to cover the daily doses until the next visit."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"Once enrolled and dosed, 2649 children (10%) subsequently refused to continue to participate."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td style="vertical-align: top;">
            <p>Rosado 2006</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td style="vertical-align: top;">
            <p>"First-grade children (n = 724) ages 6 &ndash; 8 y, attending Mexican public schools located in the vicinity of a metal foundry" </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td style="vertical-align: top;">
            <p>"Despite the known links between nutritional variables and cognition, the context of children&rsquo;s nutritional status has usually not been considered when evaluating the association between cognitive deficits and lead exposure...Thus, it is unclear from the current literature to what extent lead exposure is independently related to cognitive deficits in children, as opposed to being indirectly related via its causal or noncausal association with growth or micronutrient deficiencies."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td style="vertical-align: top;">
            <p>"over 6 months'</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td style="vertical-align: top;">
            <p>"Baseline data collection consisted of venous blood sample, anthropometry, and cognitive assessment...During cognitive assessment, both standardized and nonstandardized measures were used...<br>
              <br> Venous blood samples from fasting subjects were obtained. Whole blood was collected in 5-mL sodium heparin vacutainer tubes (Becton Dickinson). Hemoglobin (Hb) was analyzed at the schools, using a Hemocue Photometer (Hemocue AB). Zinc protoporphyrin...was tested in whole blood at the school with ZP Hematofluorometer (AVIV Biomedical). Blood samples were transported to the laboratory on ice and processed the same day. Whole blood and serum were divided into aliquots and stored at&mdash;80&deg;C until analysis. Serum ferritin (SF) was analyzed using an immunoradiographic method (Coat-A-Count Ferritin IRMA). C-reactive protein (CRP) was analyzed using the LINCON coagulation kit (Laboratorios Lincon)....Blood lead (PbB) analysis ...atomic absorption spectrophotometry (Zeeman 5100, Perkin Elmer) [<a href="#422224242545003711">17</a>]. Samples were analyzed in duplicate and those with a CV &gt; 5% were reanalyzed...<br>
              <br> Arsenic in urine was determined by hydride generation atomic absorptionspectrometry, using Perkin Elmer 3100 equipped with a FIAS-200 flow injection atomic spectroscopy system...<br>
              <br> Anthropometry. Measurements were conducted according to standard methods [<a href="#422224384111152333">18</a>]. Children took off their shoes but wore school uniforms for both weight and height assessments. Weight was measured using an upright scale (Torino, Model Express Plus) with the capacity to weigh 160 kg in 100-g increments. Height was taken using a measuring board (Mart&iacute;n, University of Guadalajara). Finally, head circumference (HC) was measured using a flexible tape (RotaryR-280).<br> Cognitive outcomes. The testing battery comprised 14 paper-and-pencil or computer-based tests covering various aspects of cognitive functioning. The tests were divided into two groups and administered on two different days. Group A consisted of Cognitive Abilities Test (CAT), the Wechsler Intelligence Scale for Children-Revised Mexican Version (WISC-RM) Coding, Digit Retention and Arithmetic; Number and Letter Sequencing, Prueba de Habilidades Cognitivas (a computer-based Test of Cognitive Abilities with 5 subtests), which were always administered in this order on d 1 of testing. On d 2, Group B, consisting of a curriculum-based Math Achievement Test (MAT), a Test of Visual-Spatial Abilities and the Peabody Picture Vocabulary Test (PPVT-Spanish Edition), was administered in the above order. The WISC-RM and the PPVT were both validated with Mexican-American populations; the rest of the tasks were piloted among 1st and 2nd graders in a public elementary school in Mexico City before the project began. The entire WISC-RM battery was not administered due to time constraints and the number of other tasks included in the testing battery...Each day&rsquo;s testing lasted for 65&ndash;70 min...there was usually no more than a week&rsquo;s lapse between Group A and B tests for any child...The testers were unaware of children&rsquo;s lead or micronutrient status. The Peabody Picture Vocabulary Test-Revised, Spanish Version [<a href="#422224423887310212">19</a>] was used to test receptive vocabulary skills and comprehension of spoken Spanish. The test consists of 111 pages, with 4 black-and-white sketches and one stimulus word per page. Children were asked to name or point to the picture that best described the given word. The raw score was converted into an age-standardized score based on a Mexican-American sample and used in statistical analyses...<br>
              <br> WISC-RM Arithmetic, Coding and Digit Span [<a href="#422224570622414436">20</a>]. WISC-RM Arithmetic is a subtest used to determine numerical reasoning skills of school children, and their ability to concentrate and integrate spoken instructions with arithmetic knowledge. Children were tested on counting, addition, subtraction, and multiplication. WISC-RM Coding tests learning of unfamiliar tasks in the form of matching two sets of symbols or numbers and symbols. The DigitSpan subtest measures short-term auditory attention and memory. Raw scores for each subscale were converted into final scores based on age-specific Spanish-language norms and used in analyses...The highest score possible was 15 for Coding and 19 for Arithmetic and Digit Span. The computer-based Cognitive Abilities Test, Stimulus Discrimination (CAT SD) Subtest [<a href="#422224618430926437">21</a>] was used to measure stimulus encoding and retrieval. CAT SD is a task consisting of a probe and test stimuli. The stimuli are squares divided into a matrix of smaller fields, filled to create unique patterns. The stimuli are chosen randomly, both for the probe and for 5 &ldquo;distracters,&rdquo; [sic] from among 24 possible matrices. During testing, children use a touch-screen to match one of 6 test stimuli to a given probe, after the probe disappears from the screen. After 4 practice trials, the test continues, without time limits, until the child completes 72 correct matches. ....Number and Letter Sequencing is a task adapted from the Trail Making Test, Trails A [<a href="#422224685417107077">22</a>, <a href="#422224661197360771">23</a>]...Number Sequencing... connect as many of the 15 encircled numbers (4 through 18) randomly distributed across a page as possible in 60 s.In Letter Sequencing...connect 15 randomly distributed letters (D-P, including the N and Q). The first 3 numbers and letters in each subtest were used for task explanation and practice...<br>
              <br> Parents...filled out a questionnaire concerning family health history, parental education and occupations, and family&rsquo;s SES [socio-economic status]. The questionnaires were self-administered but the research staff assisted parents and clarified questions. Home visits were made for parents not in attendance at the meetings. A family&rsquo;s SES index was computed on the basis questions about possessions, housing conditions, crowding, and caregiver education.Points given for individual questions were summed into a scale ranging between 5 and 12 points. Three SES levels were developed: low &lt;33% of total range), medium (33&ndash;66% of total range), and high (above 66% of total range)....Height-for-age (HAZ) and height-for-weight Z-scores (WHZ) were computed using EpiInfo...Parents completed a sleep questionnaire that was based on pediatric sleep literature...Parents reported children&rsquo;s usual bedtimes, wake-up times, and sleep onset latency. For all other items&mdash;sleep duration, frequency of night waking, duration of waking episodes, problems falling back asleep, activity during sleep, energy level in the morning, time of day the child appears tired, and frequency and duration of napping&mdash;parents chose from several answers (eg, for night waking, 0 times,1&ndash;2 times, or 3&ndash;4 times). Parents also characterized how their children behaved in the morning (eg, if they cried and fussed or wanted to sleep more)...factors that could influence sleep: who woke the children up and decided their bedtimes (self or other), whether they shared their bedrooms, whether they consumed coffee/soda or experienced anxiety at home or school...a convenience sample of 8 out of the 23 classrooms to conduct observations and measurements of physical activity...observational coding scheme allowed for on-task and several off-task behaviors...Observers entered with the children and began observing 5&ndash;10 minutes after class began until 5&ndash;10 minutes before recess, and again after lunch until 5&ndash;10 minutes before the end of school. They marked a behavior at the end of a 20-second interval and suspended observations when teachers left the classroom, restarting if their absence lasted longer than 5 minutes. Children were not observed around holidays/special activities. Each child was observed twice, once before and once after recess, for 15 minutes each time. Whenever possible, the morning and afternoon observations were completed in 1 day; some observations were spaced 2&ndash;3 days apart because of class schedules and teacher or child absences...teachers provided formal behavior ratings using the short version of the Conner&rsquo;s Behavior Rating Scales for Teachers. </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td style="vertical-align: top;">
            <p>"Investigators and school officials organized informational meetings with parents at which the study, its risks, and benefits were explained and consent forms were distributed&hellip;Anthropometry... A single person performed all weight and height measurements...Cognitive assessment...Ten Mexican psychologists evaluated the children. They were divided into teams of 2; within the team, each psychologist administered one part of the battery. Each psychologist saw 3 or 4 children every day of testing. All testers underwent a 3-wk training by a child psychologist (J.A.R.) and a standardization session at an elementary school in a neighboring town... Each tester was observed and evaluated until standardization was achieved. </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td style="vertical-align: top;">
            <p>"Nurses gave a tablet to each child with a cup of purified drinking water and made sure it was swallowed."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td style="vertical-align: top;">
            <p>"Torre&oacute;n, a highly industrialized city in the north of Mexico&hellip;Cognitive assessment...Testing took place at each school in an isolated room, with as little noise and distraction as possible."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td style="vertical-align: top;">
            <p>"1 of 4 treatments:</p>
            <p>iron only,</p>
            <p>zinc only,</p>
            <p>both iron and zinc,</p>
            <p>or placebo...</p>
            <p>iron tablets contained 30 mg ferrous fumarate,and zinc tablets contained 30 mg zinc oxide. The combined treatment tablets had 30 mg iron and 30 mg zinc. Placebo was made of a 60-mg sugar carrier. The supplements were donated by Roche Company (Mexico City, Mexico) and were indistinguishable by color."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td style="vertical-align: top;">
            <p>"Exceptions were made for children experiencing nausea whose parents wished to continue with the study. The supplements were administered to those children in the afternoons by their parents. For children who missed school, nurses provided an adequate supply of tablets for supplementation at home."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td style="vertical-align: top;">
            <p>"During the summer months the tablets were distributed at children&rsquo;s homes every 2 weeks"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td style="vertical-align: top;">
            <p>"Compliance was monitored daily at school and on a 2-week basis during the summer, as reported by parents"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"A total of 602 children...were enrolled... 527 completed the treatment, and 515 were available for long-term follow-up, after another 6 months without supplementation." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td style="vertical-align: top;">
            <p>Bobonis 2006</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>Effect of a randomized health intervention delivering iron supplementation and deworming drugs on Indian preschool children </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>2392 Preschool children aged 2 through 6 years</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>To evaluate the impact of a randomized health intervention delivering iron supplementation and deworming drugs to Indian preschool children. </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"The preschool health intervention consisted of iron supplementation (33.3 mg of elemental iron with folic acid)9 and deworming drugs (400 mg of albendazole) administered during &ldquo;health camps&rdquo; conducted three times a year and in the preschools.10 Following WHO recommendations, teachers in treatment preschools administered daily iron doses for 3 school days following each health camp, to all children attending school that day. Deworming was included since worm infections can contribute to anemia (see Hall et al. 2001 and references therein). The deworming drugs were taken at &ldquo;health camps.&rdquo; Treatment and control preschools both also received 200,000 I.U. of Vitamin A at the first health camp during the study period, and thus treatment effects should be interpreted as the impact of iron and deworming in addition to Vitamin A, relative to Vitamin A alone. Note that in addition to its potential benefits for the immune system and eyesight, Vitamin A may promote iron absorption (Food &amp; Agriculture Organization/World Health Organization 1998), so this is a potentially important interaction.11 The intervention package in treatment schools&mdash;iron, deworming, and Vitamin A together&mdash;is relatively inexpensive, with drug purchase and delivery costing approximately US$1.70 per child per year. Estimating intervention costs is complicated by the fact that enumerators carried out data collection as well as project activities, but the above figure attempts to isolate intervention costs. We do not attempt a program rate of return calculation in this paper given these concerns about disentangling evaluation and project costs, as well as the lack of reliable estimates of the long-run return to additional preschool attendance in India."<br>
              <br> 9-11 are footnotes that are described below:<br> "9. This dosage was chosen by the NGO based on pharmaceutic alavailability and the desire to provide a therapeutic intervention for a 13 kg child at close to 3 mg/kg per day, for three months (Centers for Disease Control and Prevention 1998). The U.S. National Academies of Sciences (2002) claim that up to 40 mg of daily iron is a safe dose for children. The WHO&rsquo;s recommended iron supplementation for children between the ages of 24&ndash;60 months in populations with significant iron deficiency is two mg/kg body weight per day, up to 30 mg for three months (World Health Organization 2001).<br> 10. Albendazole is a broad-spectrum anthelminthic effective against roundworm and hookworm.<br> 11. Araujo et al. (1987) documented a reduction in the percent of children with deficient or low Hb levels among children receiving iron, deworming, and Vitamin A."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Enumerators measured child height and weight at the health camps. Anthropometric measures of child weight-for-height (&ldquo;wasting,&rdquo; acute undernutrition), weight-for-age (&ldquo;underweight,&rdquo; chronic and acute malnutrition), and height-for-age (&ldquo;stunting,&rdquo; chronic" undernutrition) Z-scores proxy for nutritional status, where Z-scores reflect the standardized difference, by age and gender, from the mean of reference healthy U.S. children."<br>
              <br> "Hemoglobin (Hb) and parasitological surveys were conducted in both December 2001 and October 2002 among a subsample of the children selected for the household survey, with Group I preschool children surveyed in 2001 and Groups I and II children in 2002.12 Due to difficulties in locating children, as well as in securing their cooperation with sample collection, hemoglobin information was obtained for only 187 of the 280 sampled children and the parasitological information for only 159 children in 2001, and there were similar rates in 2002.13 Baseline Hb data was not taken in 2001 from Groups II and III children since it was thought unethical to collect such information from children who would not be treated immediately."<br>  
              <br> "A household survey collected information on socioeconomic and demographic characteristics, parent schooling, labor market outcomes, health knowledge (particularly regarding anemia and worms) and recent illness episodes for all household members. The first household survey round was administered among a representative subset of households during August-September 2001 and the second round in September&ndash;November 2002. The 2001 sample consisted of a 30 percent representative clustered sample of the child population from each preschool. In all 515 of the 715 sampled households were interviewed in 2001. Survey completion rates were imperfect due to frequent household mobility, difficulty simply locating some house- holds in these dense urban areas, and occasional refusal. Fortunately, survey completion rates were similar across the three treatment groups (at 77, 69, and 69 percent, respectively), as expected, since the preschools had not yet been divided into treatment groups. Similar difficulties affected the 2002 household survey round in which 650 of the 756 sampled households were surveyed." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Teachers were instructed to give each child in the treatment preschools 30 days of iron after each health camp." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"...preschools in poor communities in eastern Delhi during" </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>iron supplementation: 33.3 mg of elemental iron with folic acid, and deworming drugs (400 mg of albendazole) administered during &ldquo;health camps&rdquo; conducted three times a year and in the preschools, daily for 30 days once in 3 months (90 days in total)</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;<br>  
            </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"iron takeup was only recorded for the 30 preschool days following each health camp, so it is likely children received some additional days of iron between that point and the following health camp, and as a result, these reports are lower bounds on actual iron compliance."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td colspan="1" style="vertical-align: top;">
            <p>"Only 17.5 and 18.5 days of iron had been administered on average in treatment (Group I schools) in the 30 school days after the first and second health camps (in December 2001 and March 2002, respectively) though, and this was mainly due to high student absenteeism (recall that children received iron at school)." </p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Trial author</p>
          </td><td style="vertical-align: top;">
            <p>Berger 2006</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Brief name</p>
          </td><td style="vertical-align: top;">
            <p>"Efficacy of combined iron and zinc supplementation on micronutrient status and growth in Vietnamese infants"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Recipient</p>
          </td><td style="vertical-align: top;">
            <p>"...breast-fed infants, between 4 and 7 months of age"</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Why</p>
          </td><td style="vertical-align: top;">
            <p>"To evaluate the effect of combined iron&ndash;zinc supplementation on micronutrient status, growth and morbidity."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (materials)</p>
          </td><td style="vertical-align: top;">
            <p>"All the parents were informed orally and in writing about the aims and procedures of the study and written informed consents were obtained from at least one parent before enrollment into the study...To avoid vitamin A deficiency becoming a limiting factor to infant health during the study period, a dose of 100 000 IU of vitamin A was given to all infants at the start of the study...The parents were taught to bring their infant between 0700 and 0900 [sic] The field workers were provided with a list of infants and the corresponding treatment identified by a letter."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>What (procedures)</p>
          </td><td style="vertical-align: top;">
            <p>"At baseline, the infants were examined by a physician and assessed for anthropometry...</p>
            <p> 
            </p>
            <p>"Trained assistants measured weight and height monthly from baseline to the end of the study. Each assistant was responsible for the same infants all along the study. Length was measured to a precision of 1mm using a Harpenden Infant Measuring Table (CMS Weighing Equipment Ltd, UK) with a resolution of 1 mm. Each measure was taken in triplicate and length calculated as the mean of the three measures. If two measures were different by more than 3 mm, length was again measured in triplicate. Infants were weighed naked on a baby scale with a precision of 10 g (Seca, Germany). The anthropometric indicators, WAZ, HAZ and weight-for-height (WHZ) were expressed in z-scores according to the National Center for Health Statistics reference using EPI-INFO 6.0 (Centers for Disease Control and Prevention, Atlanta, GA, USA). Stunting was defined by HAZ &lt; -2 z-scores, wasting by WHZ &lt; -2 z-scores and underweight by HAZ &lt; -2 z-scores.</p>
            <p>
              <br> Nonfasting blood samples were collected in the morning between 0800 and 0010, at baseline and after 26 weeks, at the end of the intervention period. At each sampling, 3 ml venous blood was drawn using a zinc-free vacuum system; 20 ml of whole blood were immediately mixed in 5 ml of Drabkin&rsquo;s solution for assessment of Hb concentration. All tubes were kept cool and transported to the laboratory at the National Institute of Nutrition in Hanoi within 4 h. Serum was separated by centrifugation at 5000 g for 10 min at 41C. Aliquots of serum were stored at -30&deg;C until analysis of serum ferritin (SF) and zinc (SZn).<br> Hb was measured by the cyanomethemoglobin method within 12 h (Boehringher kits). SZn was assessed in duplicate by flame atomic absorption spectrometry (Perkin-Elmer Model 5000 spectrophotometer, Norwalk, USA). Before analysis, the serum samples were diluted (1:4) with deionized water...Hemolyzed serum samples were discarded to avoid interference of high zinc content from red blood cells. SF was measured by a two-site enzyme-linked immunosorbent assay (Ramco, Houston, TX, USA) using monoclonal reagents for both the capture and indicator antibodies as described previously [<a href="#422225228006166832">24</a>]...</p>
            <p> 
            </p>
            <p>The field workers who gave the supplements recorded morbidity daily. Diarrhea was defined by three or more unformed stools per day and diarrhea recovery by a 48-h diarrhea-free period. Acute respiratory infection (ARI) was defined by presence of cough or/and difficulty to breathe and/or elevated respiratory rate (RR). An elevated RR was higher than 50/min in infant and higher than 40/min in children (&gt;1 year of age)."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Who provided</p>
          </td><td style="vertical-align: top;">
            <p>"At baseline, the infants were examined by a physician and assessed for anthropometry...</p>
            <p>The supplements were given 7 days/week during 6 months by trained field workers, one in each village, recruited for the study...</p>
            <p>The quality of the work of the each field worker was checked all along the study by supervisors chosen in the commune and by members of the research team...</p>
            <p>Trained assistants measured weight and height monthly from baseline to the end of the study... field workers who gave the supplements recorded morbidity daily."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>How (mode of delivery; individual or group)</p>
          </td><td style="vertical-align: top;">
            <p>"The supplements were given 7 days/week during 6 months by trained field workers, one in each village, recruited for the study. The supplementation was given in the early morning,in a central place of each village or in the house of the fieldworker."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Where</p>
          </td><td style="vertical-align: top;">
            <p>The supplements were given 7 days/week during 6 months by trained field workers, one in each village, recruited for the study. The supplementation was given in the early morning,in a central place of each village or in the house of the fieldworker. The parents were taught to bring their infant between 0700 and 0900 The field workers were provide with a list of infants and the corresponding treatment identified by a letter. Two milliliters of syrup were given directly into the mouth of the infant using a small plastic syringe. No food or beverage were given to the infant with the supplement and the parents were instructed to wait 2 hs after the intake of syrup before giving any food or beverage.The presence of infants was noted daily. The quality of the work of the each field worker was checked all along the study by supervisors chosen in the commune and by members of the research team. New bottles of syrup were given each month to the field workers. The last distribution of syrups to the infants occurred the day before the final blood sampling.</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>When and how much</p>
          </td><td style="vertical-align: top;">
            <p>"...the Fe-group received a daily dose of 10 mg of iron as ferrous sulfate,</p>
            <p>the Zn-group a daily dose of 10 mg zinc as zinc sulfate,</p>
            <p>the Fe&ndash;Zn group a daily dose of 10 mg iron + 10 mg zinc and</p>
            <p>the placebo group a placebo.</p>
            <p>The four types of supplement were included in a sweet-tasting syrup and provided free of charge by the UNICEFSupply Division in Copenhagen. Supplements were presented in similar coded bottles avoiding participants and health workers to differentiate between treatments...To avoid vitamin A deficiency becoming a limiting factor to infant health during the study period, a dose of 100 000 IU of vitamin A was given to all infants at the start of the study.</p>
            <p>The supplements were given 7 days/week during 6 months by trained field workers, one in each village, recruited for the study....in the early morning...Two milliters of syrup were given directly into the mouth of the infant using a small plastic syringe. No food or beverage were given to the infant with the supplement and the parents were instructed to wait 2 hs after the intake of syrup before giving any food or beverage."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Tailoring</p>
          </td><td style="vertical-align: top;">
            <p>"At the end of the intervention period, all infants still anemic were referred to the health center to received iron supplements.'</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Modification of intervention throughout the trial</p>
          </td><td style="vertical-align: top;">
            <p>&mdash;</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Strategies to improve or maintain intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"The presence of infants was noted daily. The quality of the work of the each field worker was checked all along the study by supervisors chosen in the commune and by members of the research team. New bottles of syrup were given each month to the field workers."</p>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;">
            <p>Extent of intervention fidelity</p>
          </td><td style="vertical-align: top;">
            <p>"915 infants were included in the study and784 infants completed the 6-month supplementation period. The rate of dropouts (n = 131, 14.3%) was similar in each group. The main reasons for dropouts were the difficulty of parents to bring their infant every day to the syrup distribution place (93 infants stopped the treatment) or absence at the end point of intervention mainly because of refusal from parents of the second blood sampling (38). Of the784 infants who completed the study, 770 had final anthropometry measurements and 760 end point blood samples.Owing to low serum volume, end point SF was measured in676 infants whereas SZn was measured in 611 infants."</p>
          </td>
        </tr>
        <tr>
          <td colspan="2" style="vertical-align: top;">
            <p>
              <b>CAT</b>:<b> </b>Cognitive Abilities Test; <b>CAT SD</b>: <b> </b>Cognitive Abilities Test, Stimulus Discrimination; <b>d</b>: day(s); <b>HAZ</b>: height-for-age Z-scores; <b>Hb</b>: haemoglobin;<b> LAZ</b>: length-for-age Z-scores; <b>MAT</b>: Math Achievement Test;<b> mo</b>: month(s);<b> PPVT</b>: Peabody Picture Vocabulary Test;<b> SES</b>: socio-economic status; <b>SF</b>: serum ferritin; <b>SSFARM</b>: ferrous sulphate syrup; <b>SZn</b>: serum zinc; <b>WAZ</b>: weight-for-age Z-scores; <b>WHZ</b>: weight-for-height Z-scores; <b>WISC-RM</b>: <b> </b>Wechsler Intelligence Scale for Children-Revised; <b>wk</b>: week(s); <b>WLZ</b>: weight-for-length Z-scores.</p>
            <p>&mdash;: denotes not reported</p>
          </td>
        </tr>
      </table>
    </div>
    <h2>References</h2>
    <ol>
      <li id="422225289933754918">
        <span publication-type="book"><span person-group-type="author"><span>World Health Organization</span></span>. <span>Physical status: The use of and interpretation of anthropometry, Report of a WHO Expert Committee</span>. <span>World Health Organization</span>, <span>1995</span>. </span>
      </li>
      <li id="422061599901842119">
        <span publication-type="book"><span person-group-type="author"><span><span>Gibson</span> <span>RS</span></span></span>. <span>Principles of Nutritional Assessment</span>. <span>London</span>: <span>Oxford University Press</span>, <span>1990</span>. </span>
      </li>
      <li id="422223210491677505">
        <span publication-type="journal"><span person-group-type="author"><span><span>Hamill</span> <span>PV</span></span>, <span><span>Drizd</span> <span>TA</span></span>, <span><span>Johnson</span> <span>CL</span></span>, <span><span>Reed</span> <span>RB</span></span>, <span><span>Roche</span> <span>AF</span></span>, <span><span>Moore</span> <span>WM</span></span></span>. <span>Physical growth: national center for health statistics percentiles</span>. <span>American Journal of Clinical Nutrition</span> <span>1979</span>;<span>32</span>(<span>3</span>):<span>607-29</span>. [DOI: <a href="https://doi.org/10.1093/ajcn/32.3.607">10.1093/ajcn/32.3.607</a>]</span>
      </li>
      <li id="422223252774718276">
        <span publication-type="book"><span person-group-type="author"><span><span>Cortius</span> <span>HCM</span></span>, <span><span>Roth&nbsp;</span> <span>M</span></span></span>. <span>Clinical biochemistry principle and methods</span>. <span>New York</span>: <span>Walter de Gruyter Berlin</span>, <span>1974</span>. </span>
      </li>
      <li id="422223298674559813">
        <span publication-type="journal"><span person-group-type="author"><span><span>Alfrey</span> <span>CP</span></span></span>. <span>Serum ferritin assay</span>. <span>CRC Critical Reviews in Clinical Laboratory Sciences</span> <span>1978</span>;<span>9</span>(<span>3</span>):<span>179-208</span>. [DOI: <a href="https://doi.org/10.3109/10408367809150919">10.3109/10408367809150919</a>]</span>
      </li>
      <li id="422223326842719047">
        <span publication-type="journal"><span person-group-type="author"><span><span>Jacobs</span> <span>A</span></span>, <span><span>Miller</span> <span>F</span></span>, <span><span>Worwood</span> <span>M</span></span>, <span><span>Beamish</span> <span>MR</span></span>, <span><span>Wardrop</span> <span>CA</span></span></span>. <span>Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload</span>. <span>British Medical Journal</span> <span>1972</span>;<span>4</span>:<span>206-8</span>. [DOI: <a href="https://doi.org/10.1136/bmj.4.5834.206">10.1136/bmj.4.5834.206</a>]</span>
      </li>
      <li id="422223350497282961">
        <span publication-type="journal"><span person-group-type="author"><span><span>D'Haese</span> <span>PC</span></span>, <span><span>Lamberts</span> <span>LV</span></span>, <span><span>Vanheule</span> <span>AO</span></span>, <span><span>De Broe</span> <span>ME</span></span></span>. <span>Direct determination of zinc in serum by Zeeman atomic absorption spectrometry with a graphite furnace</span>. <span>Clinical Chemistry</span> <span>1992</span>;<span>38</span>(<span>12</span>):<span>2439-43</span>. [DOI: <a href="https://doi.org/10.1093/clinchem/38.12.2439">10.1093/clinchem/38.12.2439</a>]</span>
      </li>
      <li id="422223894286437548">
        <span publication-type="journal"><span person-group-type="author"><span><span>Stoltzfus</span> <span>RJ</span></span>, <span><span>Kvalsvig</span> <span>JD</span></span>, <span><span>Chwaya</span> <span>HM</span></span>, <span><span>Montresor</span> <span>A</span></span>, <span><span>Albonico</span> <span>M</span></span>, <span><span>Tielsch</span> <span>JM</span></span>, <span><span>Savioli</span> <span>L</span></span>, <span><span>Pollitt</span> <span>E</span></span></span>. <span>Effects of iron supplementation and anthelmintic treatment on motor and language development of preschool children in Zanzibar: double blind, placebo controlled study</span>. <span>BMJ</span> <span>2001</span>;<span>323</span>(<span>7326</span>):<span>1-8</span>. [DOI: <a href="https://doi.org/10.1136/bmj.323.7326.1389">10.1136/bmj.323.7326.1389</a>] [PMID: <a href="https://www.ncbi.nlm.nih.gov/pubmed/11440920">11440920</a>]</span>
      </li>
      <li id="422244973844653841">
        <span publication-type="book"><span person-group-type="author"><span><span>Griffiths</span> <span>R</span></span></span>. <span>The Abilities of Babies: a study in mental measurement</span>. <span>McGraw-Hill</span>, <span>1954</span>. </span>
      </li>
      <li id="422244999498065708">
        <span publication-type="other"><span person-group-type="author"><span><span>Hartung</span> <span>JP</span></span>, <span><span>Pethick</span> <span>S</span></span>, <span><span>Reilly</span> <span>J</span></span></span>. <span>The MacArthur Communicative Development Inventories</span>. <span>Users Guide and Technical Manual</span> <span>1993</span>.</span>
      </li>
      <li id="422245017958770592">
        <span publication-type="book"><span person-group-type="author"><span><span>Ireton</span> <span>H</span></span></span>. <span>Child development inventory</span>. <span>Minneapolis, MN</span>: <span>Behavior Science Systems</span>, <span>1992</span>. </span>
      </li>
      <li id="422245040855213986">
        <span publication-type="journal"><span person-group-type="author"><span><span>Bates</span> <span>JE</span></span>, <span><span>Freeland</span> <span>CA</span></span>, <span><span>Lounsbury</span> <span>ML</span></span></span>. <span>Measurement of infant difficultness</span>. <span>Child Development</span> <span>1979</span>;<span>50</span>(<span>3</span>):<span>794-803</span>. [PMID: <a href="https://www.ncbi.nlm.nih.gov/pubmed/498854">498854</a>]</span>
      </li>
      <li id="422245055895725988">
        <span publication-type="journal"><span person-group-type="author"><span><span>Fagan III</span> <span>JF</span></span></span>. <span>An attention model of infant recognition</span>. <span>Child Development</span> <span>1977</span>;<span>48</span>(<span>2</span>):<span>345-59</span>. [DOI: <a href="https://doi.org/10.2307/1128627">10.2307/1128627</a>]</span>
      </li>
      <li id="422245093366065063">
        <span publication-type="book"><span person-group-type="author"><span><span>Piaget</span> <span>J</span></span></span>. <span>The construction of reality in the child</span>. <span>New York</span>: <span>Basic</span>, <span>1954</span>. </span>
      </li>
      <li id="422245120936273834">
        <span publication-type="journal"><span person-group-type="author"><span><span>Smith</span> <span>LB</span></span>, <span><span>Thelen</span> <span>E</span></span>, <span><span>Titzer</span> <span>R</span></span>, <span><span>McLin</span> <span>D</span></span></span>. <span>Knowing in the context of acting: the task dynamics of the A-not-B error</span>. <span>Psychological Review</span> <span>1999</span>;<span>106</span>(<span>2</span>):<span>235</span>. [DOI: <a href="https://doi.org/10.1037/0033-295x.106.2.235">10.1037/0033-295x.106.2.235</a>] [PMID: <a href="https://www.ncbi.nlm.nih.gov/pubmed/10378013">10378013</a>]</span>
      </li>
      <li id="422245178669295537">
        <span publication-type="journal"><span person-group-type="author"><span>WHO Multicentre Growth Reference Study Group</span>, <span><span>de Onis</span> <span>M</span></span></span>. <span>WHO Motor Development Study: windows of achievement for six gross motor development milestones</span>. <span>Acta Paediatrica</span> <span>2006</span>;<span>95</span>:<span>86-95</span>. [DOI: <a href="https://doi.org/10.1111/j.1651-2227.2006.tb02379.x">10.1111/j.1651-2227.2006.tb02379.x</a>]</span>
      </li>
      <li id="422224242545003711">
        <span publication-type="journal"><span person-group-type="author"><span><span>Miller</span> <span>DT</span></span>, <span><span>Paschal</span> <span>DC</span></span>, <span><span>Gunter</span> <span>EW</span></span>, <span><span>Stroud</span> <span>PE</span></span>, <span><span>D'Angelo</span> <span>J</span></span></span>. <span>Determination of lead in blood using electrothermal atomisation atomic absorption spectrometry with a L'vov platform and matrix modifier</span>. <span>Analyst</span> <span>1987</span>;<span>112</span>(<span>12</span>):<span>1701-4</span>. [DOI: <a href="https://doi.org/10.1039/AN9871201701">10.1039/AN9871201701</a>]</span>
      </li>
      <li id="422224384111152333">
        <span publication-type="journal"><span person-group-type="author"><span><span>Habicht</span> <span>JP</span></span></span>. <span>Standardization of quantitative epidemiological methods in the field</span> [Estandarizaci&oacute;n de m&eacute;todos epidemiol&oacute;gicos cuantitativos sobre el terreno. Bolet&iacute;n de la Oficina Sanitaria Panamericana (OSP); 76 (5), mayo 1974. 1974.]. <span>Bolet&iacute;n de la Oficina Sanitaria Panamericana (OSP)</span> <span>76</span>;<span>576</span>(<span>5</span>):<span>375-84</span>. [DOI: <a href="https://doi.org/4277063">4277063</a>]</span>
      </li>
      <li id="422224423887310212">
        <span publication-type="book"><span person-group-type="author"><span>Dunn</span>, <span>LM</span>, <span>Lugo</span>, <span>DE</span>, <span>Padilla</span>, <span>ER</span>, <span><span>Dunn</span> <span>LM</span></span></span>. <span>Test de Vocabulario en Im&aacute;genes Peabody</span>. <span>Circle Pines, MN</span>: <span>American Guidance Service</span>, <span>1986</span>. </span>
      </li>
      <li id="422224570622414436">
        <span publication-type="book"><span person-group-type="author"><span><span>Wechsler</span> <span>D</span></span>, <span><span>G&oacute;mez Palacio</span> <span>M</span></span>, <span><span>Padillam</span> <span>ER</span></span>, <span><span>Roll</span> <span>S</span></span></span>. <span>Escala de Inteligencia Para Nivel Escolar Wechsler-RM</span>. <span>M&eacute;xico</span>: <span>El Manual Moderno</span>, <span>1984</span>. </span>
      </li>
      <li id="422224618430926437">
        <span publication-type="book"><span person-group-type="author"><span><span>Detterman</span> <span>DK</span></span></span>. <span>CAT: Cognitive Abilities Test</span>. <span>Cleveland, OH</span>: <span>Case Western Reserve University, Department of Psychology</span>, <span>1988</span>. </span>
      </li>
      <li id="422224685417107077">
        <span publication-type="book"><span person-group-type="author"><span><span>Reitan</span> <span>RM</span></span>, <span><span>Wolfson</span> <span>D</span></span></span>. <span>Neuropsychological Evaluation of Older Children</span>. <span>Neuropsychology Press</span>, <span>1992</span>. </span>
      </li>
      <li id="422224661197360771">
        <span publication-type="journal"><span person-group-type="author"><span><span>Wolf</span> <span>AW</span></span>, <span><span>Jimenez</span> <span>E</span></span>, <span><span>Lozoff</span> <span>B</span></span></span>. <span>No evidence of developmental ill effects of low-level lead exposure in a developing country</span>. <span>Journal of Developmental and Behavioral Pediatrics</span> <span>1994</span>;<span>15</span>(<span>4</span>):<span>224-31</span>. [DOI: <a href="https://doi.org/10.1097/00004703-199408000-00002">10.1097/00004703-199408000-00002</a>]</span>
      </li>
      <li id="422225228006166832">
        <span publication-type="journal"><span person-group-type="author"><span><span>Flowers</span> <span>CA</span></span>, <span><span>Kuizon</span> <span>M</span></span>, <span><span>Beard</span> <span>JL</span></span>, <span><span>Skikne</span> <span>BS</span></span>, <span><span>Covell</span> <span>M</span></span>, <span><span>Cook</span> <span>JD</span></span></span>. <span>A serum ferritin assay for prevalence studies of iron deficiency</span>. <span>American Journal of Hematology</span> <span>1986</span>;<span>23</span>(<span>2</span>):<span>141-51</span>. [DOI: <a href="https://doi.org/10.1002/ajh.2830230209">10.1002/ajh.2830230209</a>]</span>
      </li>
    </ol>
  </body>
</html>
